A starch- and sucrose-reduced dietary intervention in irritable bowel syndrome patients produced a shift in gut microbiota composition along with changes in phylum, genus, and amplicon sequence variant abundances, without affecting the micro-RNA levels.
Clara NilholmLokeshwaran ManoharanBodil RothMauro D'AmatoBodil OhlssonPublished in: United European gastroenterology journal (2022)
The SSRD induced a shift in beta diversity along with several bacteria at different levels, associated with changes in nutrient intakes and reduced gastrointestinal symptoms. No corresponding changes were observed in the control group. Neither the nutrient intake nor the microbiota changes affected micro-RNA expression. The study was registered at ClinicalTrials.gov data base (NCT03306381).
Keyphrases
- irritable bowel syndrome
- end stage renal disease
- randomized controlled trial
- newly diagnosed
- ejection fraction
- poor prognosis
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- electronic health record
- machine learning
- nucleic acid
- diabetic rats
- body mass index
- weight loss
- artificial intelligence
- deep learning